Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response

Journal of Controlled Release

Volumn 54, Issue 1, 1998, Pages 49-59

  Newman, K D ^a   Samuel, J ^a   Kwon, G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antigen delivery system; MPLA; OVA peptide; PLGA microspheres; Th1 response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MICROSPHERE; OVALBUMIN; PHOSPHORYL LIPID A; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MICROENCAPSULATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; DRUG CARRIERS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LACTIC ACID; MICE; MICE, INBRED C57BL; MICROSPHERES; MOLECULAR SEQUENCE DATA; OVALBUMIN; POLYGLYCOLIC ACID; POLYMERS; TH1 CELLS;

EID: 0031783218     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00142-9     Document Type: Article

References (50)

1. L. Preis, R.S. Langer, A single-step immunization by sustained antigen release, J.Immunol. Methods 28 (1979) 193-197.
2. D.K. Gilding, A.M. Reed, Biodegradable polymers for use in surgery polyglycolic/poly(lactic acid) homo- and copolymers, Polymer 20 (1979) 1459-1464.
3. D.L. Wise, T.D. Fellmann, J.E. Sanderson, R.L. Wentworth, Lactic/glycolic acid polymers, in: G. Gregoriadis (Ed.), Drug Carriers in Biology and Medicine, Academic Press, London, 1979, pp. 237-270.
4. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, J.R. McGhee, T.R. Tice, R.M. Gilley, Biodegradable microspheres as a vaccine delivery system, Mol. Immunol. 28 (1991) 287-294.
5. R.A. Miller, J.M. Brady, D.E. Cutwright, Degradation rates of resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios, J. Biomed. Mater. Res. 11 (1977) 711-719.
6. D.E. Cutright, E. Perry, J.D. Beasley, W.J. Larson, W.R. Perry, Degradation of poly(lactic acid) polymer and copolymer of poly(glycolic acid), J. Oral. Surg. 37 (1974) 142-152.
7. F.G. Hutchinson, B.J.A. Furr, Biodegradable polymers in sustained release of polypeptides, in: S.S. Davis, L. Illum, E. Tomlinson (Eds.), Delivery Systems for Peptide Drugs, Plenium Press, New York, 1986, pp. 115-124.
8. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice, R.M. Gilley, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhance the level of toxin-neutralizing antibodies, Infect. Immun. 59 (1991) 2978-2985.
9. F.D. Finkelman, K.B. Madden, A.W. Cheever, I.M. Katona, S.C. Morris, M.K. Gately, B.R. Hubbard, W.C. Gause, J.F. Urban Jr., Effects of interleukin 12 on the immune responses and host protection in mice infected with intestinal nematode parasites, J. Exp. Med. 179 (1994) 1563-1572.
10. E. Pearlman, W.K. Kroeze, F.E. Hazlett, S.A. Chen, S.D. Mawhorter, W.H. Boom, J.W. Kazura, Brugia malayi: Acquired resistance to microfilariae in Balb/c mice correlates with local Th2 responses, Exp. Parasitol. 76 (1993) 200-208.
11. A. Keane-Myers, S.P. Nickell, Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burdorferi in mice, J. Immunol. 155 (1995) 2020-2028.
12. P. Scott, E. Pearce, A.W. Cheever, R.L. Coffman, A. Sher, Role of cytokines and CD4+T-cell subsets in the regulation of parasite immunity and disease, Immunol. Rev. 112 (1989) 161-182.
13. M. Clerici, G.M. Shearer, A Th1→Th2 switch is a critical step in the etiology of HIV infection, Immunol. Today 14 (1993) 107-111.
14. T.R. Mosmann, Cytokine patterns during the progression to AIDS, Science 265 (1994) 193-194.
15. T. Boon, Teaching the immune system to fight cancer, Sci. Am. 268(3) (1993) 82-89.
16. G.J.V. Nossal, Life, death and the immune system, Sci. Am. 269(3) (1993) 52-62.
17. T.R. Mosmann, R.L. Coffman, Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol. 7 (1989) 145-173.
18. M. Yamamura, K. Uyemura, R.J. Deans, K. Weinberg, T.H. Rea, B.R. Bloom, R.L. Modlin, Defining protective responses to pathogens: cytokine profiles in leprosy lesions, Science 254 (1991) 277-279.
19. A. Tsicopoulos, Q. Hamid, V. Varney, S. Ying, R. Moqbel, S.R. Durham, A. Barry Kay, Preferential messenger RNA expression of Th1-type cells (IFN-G+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin, J. Immunol. 148 (1992) 2058-2061.
20. J. Kuby, Immunology, 2nd ed., W.H. Freeman and Company, New York, 1994.
21. T.R. Mosmann, H.M. Cherwinski, M.W Bond, M.A. Giedlin, R.L. Coffman, Two Types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol. 136 (1986) 2348-2357.
22. H.M. Cherwinski, J.H. Schumacher, K.D. Brown, T.R. Mosmann, Two types of mouse helper T cell clone III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies, J. Exp. Med. 166 (1987) 1229-1244.
23. G.F. Del Prete, M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci, S. Romagnani, Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T Cells with stable and opposite (type 1 T Helper or type 2 T Helper) profile of cytokine production, J. Clin. Invest. 88 (1991) 346-350.
24. D.F. Fiorentino, M.W. Bond, T.R. Mosmann, Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, J. Exp. Med. 170 (1989) 281-295.
25. Y. Sanchez, I. lonescu-Matin, G.R. Dreesman, W. Kramp, H.R. Six, F.B. Hollinger, J.L. Mellnick, Humoral and cellular immunity to hepatitis B virus-derived antigen: comparative activity of Freund's complete adjuvant, alum and liposome, Infect. Immunity 30 (1980) 728-733.
26. A. Childerstone, J.A. Haron, T. Lehner, T cell interaction generated by synthetic peptides covalently linked to a carrier, Eur. J. Immunol. 19 (1989) 169-176.
27. M.P. Schutze, C. Leclerc, M. Jolivet, F. Audibert, L. Chedid, Carrier-induced epitopic suppression, a major issue for future synthetic vaccines, J. Immunol. 135 (1985) 2319-2322.
28. V. Apostolopoulos, P.X. Xing, I.F. McKenzie, Murine immune response to cells transfected with human MUC1: Immunization with cellular and synthetic antigens, Cancer Res. 54 (1994) 5186-5193.
29. J.R Briand, S. Muller, R. Van, Synthetic peptides as antigens: pitfalls of conjugation methods, J. Immunol. Methods 78 (1985) 59-69.
30. H. Renz, K. Bradley, G.L. Larsen, C. McCall, E.W. Gelfand, Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339, J. Immunol. 151(12) (1993) 7206-7213.
31. J.T. Ulrich, K.R. Myers, Monophosphoryl lipid A as an adjuvant. Past experiences and new directions, in: M.F. Powell, M.J. Newman (Eds.), Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York, 1995, pp. 495-524.
32. Y. Ogawa, M. Yamamoto, H. Okada, T. Yashiki, T. Shimamoto, A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid, Chem. Pharm. Bull. 36(3) (1988) 1095-1103.
33. G. Zheng, G.D. Leesman, A novel method for the determination of 3-O-deacyl-4′-monophosphoryl lipid A with high performance liquid chromatography employing fluorometric detection, Pharm. Res. 13(9 (September, supplement, abstract)) (1996) S-29.
34. S. Degermann, E. Pria, L. Adorini, Soluble protein but not peptide administration diverts the immune response of a clonal CD4+T cell population to the T helper 2 cell pathway, J. Immunol. 157(8) (1996) 3260-3269.
35. D.R. Milich, Synthetic peptides: prospects for vaccine development, Semin. Immunol. 2 (1990) 307-315.
36. Y. Men, C. Thomasin, H.P. Merkle, B. Gander, G. Corradin, A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide, Vaccine 13(7) (1995) 683-689.
37. D.T. O'Hagan, H. Jeffery, S.S. Davis, Long-term antibody responses following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles, Vaccine 11(9) (1993) 965-969.
38. D.T. O'Hagan, J.P. McGee, J. Holmgren, A. MC1 Mowat, A.M. Donachie, K.H.G. Milla, W. Gaisford, D. Rahman, S.J. Challcombe, Biodegradable microparticles for oral immunization, Vaccine 11(2) (1993) 149-154.
39. K. Maloy, A.M. Donachie, D.T. O'Hagan, A.MC1 Mowat, Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles, Immunology 81 (1994) 661-667.
40. J.H. Eldridge, J.K. Staas, D. Chen, P.A. Marx, T.R. Tice, R.M. Gilley, New advances in vaccine delivery systems, Semin. Hematol. 30(4) (1993) 16-25.
41. D.T. O'Hagan, D. Rahman, J.P. McGee, H. Jeffery, M.C. Davies, P. Williams, S.S. Davis, S.J. Challacombe, Biodegradable microparticles as controlled release antigen delivery systems, Immunology 73 (1991) 239-242.
42. H.C J. Ertl, I. Varga, Z.Q. Xiang, K. Kaiser, L. Stephens, L. Otvos Jr., Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines, Vaccine 14(9) (1996) 879-885.
43. H.S. Warren, L.A. Chedid, Future prospects for vaccine adjuvants, Crit. Rev. Immunol. 8 (1988) 83-101.
44. A. Moore, P. McGuirk, S. Adams, W.C. Jones, J.P. McGee, D.T. O'Hagan, K.H.G. Mills, Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+Th1 cells, Vaccine 13(18) (1995) 1741-1749.
45. C.D. Partidos, P. Vohra, C. Anagnostopoulou, D.H. Jones, G.H. Farrar, M.W Steward, Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes, Mol. Immunol. 33(6) (1996) 485-491.
46. G. Johnsen, S. Elsayed, Antigenic and allergenic determinants of ovalbumin. III. MHC Ia-binding peptide (OA 323-339) interacts with human and rabbit specific antibodies, Mol. Immunol. 27(9) (1990) 821-827.
47. C.R. Parish, The relationship between humoral and cell-mediated immunity, Trans. Rev. 13 (1972) 35-66.
48. P.A. Bretscher, G. Wei, J.N. Menon, H. Bielefeldt-Ohmann, Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major, Science 257 (1992) 539-542.
49. T.R. Mosmann, S. Sad, The expanding universe of T cell subsets: Th1, Th2 and more, Immunol. Today 17(3) (1996) 138-146.
50. R. Loman, C. Sedlik, C. Leclerc, Presentation de l'antigene aux cellules Th1 et Th2, Rev. Fr. Allergol. 35(6) (1995) 565-569.